Influence of immunotherapy with pegylated interferon-alpha on platelet monoamine oxidase activity in high-risk melanoma patients

被引：0
|
作者：
Fekkes, D [1 ]
van Gool, AR [1 ]
van Ojik, HH [1 ]
Bannink, M [1 ]
Mulder, PGH [1 ]
Kruit, WHJ [1 ]
Eggermont, AMM [1 ]
Stoter, G [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80165-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [1] Influence of pegylated interferon-alpha on the nitric oxide system in high-risk melanoma patients
    Fekkes, D
    Bannink, M
    Kruit, WHJ
    Sleijfer, S
    Mulder, PGH
    Eggermont, AMM
    Stoter, G
    Van Gool, AR
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S408 - S408
  • [2] Influence of immunotherapy with interferon-alpha on serum amino acids, biopterin and neopterin in high risk melanoma patients
    Van Gool, AR
    Fekkers, D
    Kruit, WHJ
    Ten Hagen, TLM
    Bannink, M
    Maes, M
    Eggermont, AMM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S242 - S242
  • [3] Cost-effectiveness (CE) analysis of interferon-alpha in high-risk melanoma patients
    Ding, M
    Xing, Y
    Shih, T
    Cox, D
    Cantor, S
    Cormier, J
    VALUE IN HEALTH, 2004, 7 (03) : 221 - 221
  • [4] Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients
    Van Gool, AR
    Fekkes, D
    Kruit, WHJ
    Mulder, PGH
    Ten Hagen, TLM
    Bannink, M
    Maes, M
    Eggermont, AMM
    PSYCHIATRY RESEARCH, 2003, 119 (1-2) : 125 - 132
  • [5] Effect of therapy with interferon-alpha and pegylated interferon-alpha on platelet plug formation in patients with chronic hepatitis C
    Homoncik, M
    Jessner, W
    Sieghardt, W
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 145 - 145
  • [6] Adjuvant Interferon-Alpha Treatment for High-Risk Melanoma Patients: A Single Tertiary Care Center Experience
    Allen, K.
    Graham, N.
    Godbout, L.
    Young, V
    Verma, S.
    Song, X.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 61 - 61
  • [7] Malignant melanoma - Interferon alpha: an important option in the therapy of high-risk patients
    不详
    HAUTARZT, 2005, 56 (12): : 1190 - 1190
  • [8] BIOCHEMICAL HIGH-RISK PARADIGM - BEHAVIORAL AND FAMILIAL CORRELATES OF LOW PLATELET MONOAMINE-OXIDASE ACTIVITY
    BUCHSBAUM, MS
    COURSEY, RD
    MURPHY, DL
    SCIENCE, 1976, 194 (4262) : 339 - 341
  • [9] Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma
    Navid, Fariba
    Herzog, Cynthia E.
    Sandoval, John
    Daryani, Vinay M.
    Stewart, Clinton F.
    Gattuso, Jami
    Mandrell, Belinda
    Phipps, Sean
    Chemaitilly, Wassim
    Sykes, April
    Davidoff, Andrew M.
    Shulkin, Barry L.
    Bahrami, Armita
    Furman, Wayne L.
    Mao, Shenghua
    Wu, Jianrong
    Schiff, Deborah
    Rao, Bhaskar
    Pappo, Alberto
    PEDIATRIC BLOOD & CANCER, 2016, 63 (07) : 1207 - 1213
  • [10] Combined adjuvant radiation and interferon-alpha 2B therapy in high-risk melanoma patients: The potential for increased radiation toxicity
    Hazard, LJ
    Sause, WT
    Noyes, RD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03): : 796 - 800
12345